Lgr5 over-expression is positively related to the tumor progression and HER2 expression in stage pTNM IV colorectal cancer.

Fengjuan Gao(Eye & ENT Hospital of Fudan University), Qin Huang(People's Hospital of Xinjiang Uygur Autonomous Region), Xiangshan Fan(Anhui Medical University), Jiong Shi(Nanjing Drum Tower Hospital), Hongyan Wu(Hong Kong Baptist University), Jieyu Chen(Nanjing Drum Tower Hospital), Ming Chen(First Affiliated Hospital Zhejiang University)
PubMed
January 1, 2014
Cited by 18

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2012|396
Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver.
|Journal of Biological Chemistry|1993|375
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
|Leukemia|2012|362
Osimertinib after Chemoradiotherapy in Stage III <i>EGFR</i> -Mutated NSCLC
|New England Journal of Medicine|2024|291